Ambrosia artemisiifolia pollen

Identification

Summary

Ambrosia artemisiifolia pollen is an extract from Ambrosia artemisiifolia pollen used in allergy testing.

Brand Names
Ragwitek
Generic Name
Ambrosia artemisiifolia pollen
DrugBank Accession Number
DB10385
Background

Ambrosia artemisiifolia pollen is the pollen of the Ambrosia artemisiifolia plant. Ambrosia artemisiifolia pollen is mainly used in allergenic testing.

Type
Biotech
Groups
Approved
Biologic Classification
Allergenics
Allergen Extract
Synonyms
  • Ambrosia artemisiifolia
  • short ragweed pollen extract
  • short ragweed pollen extracts
  • Standardized short ragweed pollen allergenic extract

Pharmacology

Indication

Ambrosia artemisiifolia pollen is an allergen extract indicated as immunotherapy for the treatment of short ragweed pollen-induced allergic rhinitis, with or without conjunctivitis, confirmed by positive skin test or in vitro testing for pollen-specific IgE antibodies for short ragweed pollen. It is approved for use in persons five through 65 years of age.

This allergen extract is not indicated for the immediate relief of allergic symptoms.1

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Indication TypeIndicationCombined Product DetailsApproval LevelAge GroupPatient CharacteristicsDose Form
Management ofAllergic rhinitis (disorder)••••••••••••••••••
Management ofAsthma•••••••••••••••••••••• •••••••• •• •••••••••••• •••••••
Management ofPollen allergy•••••••••••••••••••••• •••••••• •• •••••••••••• •••••••
Associated Therapies
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Brand Name Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Ambrosia Artemisiifolia PollenInjection, solution0.05 g/1mLSubcutaneousALK-Abello, Inc.1965-01-01Not applicableUS flag
Ambrosia Artemisiifolia PollenInjection, solution40000 [PNU]/1mLSubcutaneousALK-Abello, Inc.1965-01-012021-11-30US flag
Ambrosia Artemisiifolia PollenInjection, solution0.10 g/1mLSubcutaneousALK-Abello, Inc.1965-01-01Not applicableUS flag
Ambrosia Artemisiifolia PollenInjection, solution20000 [PNU]/1mLSubcutaneousALK-Abello, Inc.1965-01-012023-05-18US flag
Center-AL - Ambrosia Artemisiifolia PollenInjection, suspension10000 [PNU]/1mLSubcutaneousALK-Abello, Inc.1975-01-152023-05-16US flag
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
3-ragweed Mix, Giant/short/western PollenAmbrosia artemisiifolia pollen (0.34 g/20mL) + Ambrosia psilostachya pollen (0.33 g/20mL) + Ambrosia trifida pollen (0.33 g/20mL)Injection, solutionPercutaneous; SubcutaneousAllergy Laboratories, Inc.1967-12-07Not applicableUS flag
Mixed RagweedAmbrosia artemisiifolia pollen (10000 [PNU]/1mL) + Ambrosia trifida pollen (10000 [PNU]/1mL)Injection, solutionSubcutaneousALK-Abello, Inc.1965-01-012023-05-19US flag
Mixed RagweedAmbrosia artemisiifolia pollen (0.1 g/1mL) + Ambrosia trifida pollen (0.1 g/1mL)Injection, solutionSubcutaneousALK-Abello, Inc.1965-01-01Not applicableUS flag
Mixed RagweedAmbrosia artemisiifolia pollen (10000 [PNU]/1mL) + Ambrosia trifida pollen (10000 [PNU]/1mL)Injection, solutionSubcutaneousALK-Abello, Inc.1975-01-15Not applicableUS flag
Mixed RagweedAmbrosia artemisiifolia pollen (0.05 g/1mL) + Ambrosia trifida pollen (0.05 g/1mL)Injection, solutionPercutaneousALK-Abello, Inc.1998-02-23Not applicableUS flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Allergen Pack Gs Ragweed MixAmbrosia artemisiifolia pollen (1 g/20mL) + Sodium chloride (0.9 g/1mL)KitIntradermal; SubcutaneousAlvix Laboratories2015-07-092018-03-08US flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
9W34L2CQ9A
CAS number
Not Available

References

General References
  1. DailyMed Label: RAGWITEK (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use [Link]
  2. DailyMed Label: SHORT RAGWEED (ambrosia artemisiifolia) injection for cutaneous, subcutaneous, or intradermal use [Link]
PubChem Substance
347910560
RxNav
1347557

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, solutionPercutaneous; Subcutaneous
KitIntradermal; Subcutaneous
Injection, solutionSubcutaneous0.05 g/1mL
Injection, solutionSubcutaneous0.10 g/1mL
Injection, solutionSubcutaneous20000 [PNU]/1mL
Injection, solutionSubcutaneous40000 [PNU]/1mL
Injection, suspensionSubcutaneous10000 [PNU]/1mL
Injection, suspensionSubcutaneous20000 [PNU]/1mL
Tablet, orally disintegratingSublingual
Injection, solutionPercutaneous
Injection, solutionSubcutaneous
SolutionIntradermal; Percutaneous; Subcutaneous
Injection, solutionIntradermal500 [PNU]/1mL
Injection, solutionPercutaneous; Subcutaneous0.05 g/1mL
Injection, solutionIntradermal
TabletSublingual12 [Amb'a'1'U]/1
Tablet, orally disintegratingSublingual12 unit
PowderOral12 SQ-Amb
InjectionCutaneous; Intradermal; Subcutaneous1 g/10mL
Injection, solutionPercutaneous0.05 g/1mL
Injection, solutionIntradermal; Subcutaneous0.05 g/1mL
Injection, solutionIntradermal; Subcutaneous0.1 g/1mL
Injection, solutionIntradermal; Subcutaneous20000 [PNU]/1mL
Injection, solutionIntradermal; Subcutaneous40000 [PNU]/1mL
SolutionIntradermal; Percutaneous; Subcutaneous0.05 g/1mL
Injection, solutionIntradermal; Subcutaneous100000 [AU]/1mL
Injection, solutionPercutaneous; Subcutaneous1 g/10mL
Injection, solutionIntradermal; Subcutaneous
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at December 01, 2015 20:03 / Updated at June 03, 2022 07:24